Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.01 +0.91 (+1.59%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
48 49 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare business. "It’s not a healthcare business that is a retailer, and retail... 
Via Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend. 
Via The Motley Fool
WBA Stock Jumps On Upgrade, Target Hike. New CEO, 'New Era' Analyst Says
JPMorgan expects Walgreens' new CEO to usher in "a new era" for the Dow Jones giant. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why This Drugstore Will Avoid Rite Aid’s Bankruptcy Fate
The top three drugstores are having a meltdown due to pressures. Today, I’ll walk through what those pressures are, each company’s issues, and point out which one of these drugstores is unfairly... 
Via Talk Markets
Topics Bankruptcy
Exposures Financial Legal
CVS Health Unusual Options Activity For October 17
Via Benzinga
What's Going On With CVS Health Stock?
CVS Health Corp (NYSE: CVS) shares are trading higher by 2.1% to $72.38 Friday morning. 
Via Benzinga
CVS Removes Certain Cold, Cough Products With Phenylephrine From Shelves: Report
CVS Health Corp (NYSE: CVS) has reportedly decided to remove specific decongestant products from its stores after an advisory by a panel to U.S. health regulators found an ingredient in these products,... 
Via Benzinga
In Need of a Turnaround: Will Walgreens' New CEO Cut or Spare Its High-Yield Dividend?
A healthcare and pharmaceutical benefits manager veteran is coming in to lead the turnaround. 
Via The Motley Fool
Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NASDAQ: MDLZ), has "fantastic" 
Via Benzinga
Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
Walgreens stock became a clear value play, offering an attractive dividend yield and tailwinds to position it as an industry leaders are two reasons to watch 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Economy
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
Benzinga Bitcoin Spiked On False ETF Approval Rumor 
Via Benzinga
Topics ETFs
3 Reasons to Buy CVS Health Stock Right Now
The stock is looking sick right now, but that won't last forever. 
Via The Motley Fool
Nationwide Walkout Looms for Walgreens, CVS Pharmacy Staff Over Working Conditions
Walgreens Boots Alliance Inc (NASDAQ: WBA) and CVS Health Corp (NYSE: CVS) CVS pharmacy staff are reportedly planning a nationwide walkout and multiple rallies in late October to pr 
Via Benzinga
Novavax (NVAX) Stock Slides Despite Vaccine Availability
Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing. 
Via InvestorPlace
3 Key Factors That Could Drive Amazon Stock Higher in the Coming Months
Amazon is an easy company to bet on, and these factors could drive AMZN stock price to new heights in the coming months. 
Via InvestorPlace
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. 
Via Benzinga
Should You Still Buy the S&P 500's Best-Performing September Stocks?
Any stock that defies a marketwide bearish tide for an entire month deserves a closer look. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.  
Via Benzinga
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Top Healthcare Stocks That Pay Dividends
With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends. 
Via InvestorPlace
The 3 Top Value Stocks to Watch in Q4 2023
Embrace financial growth with top value stocks. Get comprehensive insights and make informed decisions for a prosperous investment journey. 
Via InvestorPlace
Big Pharma's Weight Loss Drugs Vs. Snacking Industry: Who Will Prevail?
The rising prevalence of obesity and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO) Wegovy and Ozempic is triggering concerns among investors about the future of the snacking industry.  
Via Benzinga
Walgreens Ends Partnership with Microsoft-Backed Cooler Screens Amidst Technical Failures
A partnership gone sour marks the end of a technological endeavor between Walgreens Boots Alliance Inc (NASDAQ: WBA) and Cooler Screens, a vendor specializing in digital advertising screens.  
Via Benzinga
2 Exceptional Dividend Stocks to Buy in October and Hold Forever
Temporary challenges are creating bargain opportunities for investors with a long-term mindset. 
Via The Motley Fool
Here's the Michael Burry Stock That Could Be the Biggest Winner Over the Next 5 Years
The "Big Short" investor just might be a big winner with this stock. 
Via The Motley Fool
Pharmacy Retailer Giant Walgreens Considers Former Cigna Exec For CEO Role
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly considering appointing Tim Wentworth, a former executive at Cigna Group (NYSE: CI), as its next CEO amid a search for leadership 
Via Benzinga
Some Economics Of Pharmacy Benefit Managers
It is a common belief, that if you could just “cut out the middleman” and “pass the savings along to consumers,” everyone would be better off. Pharmacy benefit managers are quintessential middlemen. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Retail Stocks to Sell Before the Damage Is Done
Macy's, Best Buy and Walgreens Boots Alliance are three retail stocks to sell in 2023 before the damage is done. 
Via InvestorPlace
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.